Skip to main content

Table 1 Association between plasma enzymatic activity of AMY1 or AMY2 and metabolic traits in D.E.S.I.R.

From: Relationship between salivary/pancreatic amylase and body mass index: a systems biology approach

Traits/disorders

AMY1

AMY2

n

Effect size ± SEa

P value

n

Effect size ± SEa

P value

BMI (kg/m2)

3673

−0.0013 ± 0.0002

2.4 × 10−13

3905

−0.0024 ± 0.0003

2.0 × 10−16

FG (mmol/L)

3629

−0.0019 ± 0.0006

1.4 × 10−3

3860

−0.0026 ± 0.0010

9.2 × 10−3

FI (pmol/L)

3625

0.0003 ± 0.0006

0.63

3856

0.0025 ± 0.0009

7.5 × 10−3

HOMA-2B

3343

0.0010 ± 0.0004

9.0 × 10−3

3548

0.0017 ± 0.0006

4.6 × 10−3

HOMA-2IR

3343

0.0004 ± 0.0005

0.40

3548

0.0007 ± 0.0008

0.36

HDL (mmol/L)

3432

0.0015 ± 0.0005

2.1 × 10−3

3637

−0.0005 ± 0.0008

0.58

LDL (mmol/L)

3427

0.0006 ± 0.0011

0.61

3632

−0.0006 ± 0.0019

0.74

TG (mmol/L)

3463

0.0003 ± 0.0006

0.68

3673

0.0003 ± 0.0010

0.81

ApoB (g/L)

3463

0.0001 ± 0.0003

0.83

3673

−0.0008 ± 0.0005

0.11

ApoA1 (g/L)

3463

0.0008 ± 0.0003

0.016

3673

−0.0009 ± 0.0005

0.10

SBP (mm Hg)

3245

−0.0063 ± 0.017

0.71

3452

−0.067 ± 0.029

0.020

DBP (mm Hg)

3245

0.0010 ± 0.011

0.93

3452

−0.013 ± 0.019

0.48

GGT (IU/L)

3744

−0.0025 ± 0.042

0.95

3980

0.021 ± 0.075

0.79

ALT (IU/L)

3741

0.032 ± 0.021

0.13

3977

−0.025 ± 0.035

0.47

AST (IU/L)

3741

0.0017 ± 0.0004

4.1 × 10−5

3977

0.0002 ± 0.0007

0.76

  1. aEffect size according to adjusted linear regression model. BMI, AST, FI, HOMA-2B, HO MA-2IR, and TG were logarithmically transformed before statistical analysis
  2. ALT alanine aminotransferase, AMY1 salivary amylase, AMY2 pancreatic amylase, ApoA1 apolipoprotein A1, ApoB apolipoprotein B, AST aspartate aminotransferase, BMI body mass index, CI confidence interval, DBP diastolic blood pressure, FG fasting plasma glucose, FI fasting serum insulin, GGT gamma-glutamyl transferase, HDL high-density lipoprotein, HOMA-2B homeostasis model assessment of beta-cell function, HOMA-2IR homeostasis model assessment of insulin resistance, LDL low-density lipoprotein cholesterol, SBP systolic blood pressure, SE standard error, TG triglyceride